CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 89 filers reported holding CHEMOCENTRYX INC in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $983,000 | -37.6% | 19,030 | -70.1% | 0.01% | -40.0% |
| Q2 2022 | $1,576,000 | +93.1% | 63,599 | +95.4% | 0.01% | +42.9% |
| Q1 2022 | $816,000 | -41.8% | 32,540 | -15.5% | 0.01% | -46.2% |
| Q4 2021 | $1,402,000 | +781.8% | 38,498 | +312.8% | 0.01% | +550.0% |
| Q3 2021 | $159,000 | -20.5% | 9,327 | -37.4% | 0.00% | 0.0% |
| Q2 2021 | $200,000 | -20.9% | 14,900 | +201.8% | 0.00% | -33.3% |
| Q1 2021 | $253,000 | -51.2% | 4,937 | -41.0% | 0.00% | -57.1% |
| Q4 2020 | $518,000 | -19.9% | 8,368 | -29.2% | 0.01% | -30.0% |
| Q3 2020 | $647,000 | -82.3% | 11,814 | -81.4% | 0.01% | -84.1% |
| Q2 2020 | $3,654,000 | +2012.1% | 63,500 | +1376.7% | 0.06% | +1160.0% |
| Q1 2020 | $173,000 | -76.1% | 4,300 | -76.5% | 0.01% | -61.5% |
| Q4 2019 | $723,000 | +297.3% | 18,282 | -31.7% | 0.01% | +225.0% |
| Q3 2019 | $182,000 | -39.5% | 26,781 | -17.3% | 0.00% | -33.3% |
| Q2 2019 | $301,000 | +18.5% | 32,370 | +68.0% | 0.01% | -53.8% |
| Q2 2018 | $254,000 | +179.1% | 19,271 | +56.4% | 0.01% | +85.7% |
| Q4 2016 | $91,000 | +2933.3% | 12,322 | +3461.3% | 0.01% | – |
| Q4 2015 | $3,000 | – | 346 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |